PUBLICATIONS · 1386272
Phase III randomised study of zoladex versus stilboestrol in the treatment of advanced prostate cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Urol
- Publication date
- 1992 Jun
- First author
- Waymont B
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Waymont B
- type
- Author
- name
- Lynch TH
- type
- Author
- name
- Dunn JA
- type
- Author
- name
- Emtage LA
- type
- Author
- name
- Arkell DG
- type
- Author
- name
- Wallace DM
- type
- Author
- name
- Blackledge GR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Waymont B
- type
- Author
- name
- Lynch TH
- type
- Author
- name
- Dunn JA
- type
- Author
- name
- Emtage LA
- type
- Author
- name
- Arkell DG
- type
- Author
- name
- Wallace DM
- type
- Author
- name
- Blackledge GR
- type
- Author
- bibliography ids
- nci-bib-ea6f624886883218a6040fa5
- book metadata
- content sha256
- 6b67805d3415d1d67569dc83059c3c262ebb4dc052347cfeaa566a86281f31df
- document type
- citation
- dois
- 10.1111/j.1464-410x.1992.tb15633.x
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:1386272
- immutable id
- pubmed:1386272@6b67805d3415d1d67569dc83059c3c262ebb4dc052347cfeaa566a86281f31df
- journal
- abbreviation
- Br J Urol
- issn electronic
- Source null
- issn print
- 0007-1331
- issue
- 6
- name
- British journal of urology
- nlm unique id
- 15740090R
- pages
- 614-20
- volume
- 69
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 1386272
- provenance
- batch id
- a0a1edf07d2c8b32d054
- provider
- NCBI PubMed ESummary
- record sha256
- 60aa2fd8841c30e5b6899e521b4869ac6489d10ab72a069ac198001b68c17a0a
- response sha256
- 963b26e86e4619ee230bdf4421d4a6bcc6f03eee0a79718c660c7d40a3c066da
- retrieved at
- 2026-09-09T23:45:05.141944+00:00
- publication date
- display
- 1992 Jun
- precision
- month
- year
- 1992
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/1386272/
- title
- Phase III randomised study of zoladex versus stilboestrol in the treatment of advanced prostate cancer.
Preserved source evidence · Not medical advice
Triangle